HCA Holdings, Inc. (NYSE:HCA) Position Raised by Boston Partners
Boston Partners increased its stake in shares of HCA Holdings, Inc. (NYSE:HCA) by 17.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 745,682 shares of the company’s stock after buying an additional 111,777 shares during the period. Boston Partners’ holdings in HCA Holdings were worth $65,023,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Lee Financial Co bought a new position in HCA Holdings during the second quarter valued at about $125,000. IFP Advisors Inc increased its position in HCA Holdings by 9.4% in the first quarter. IFP Advisors Inc now owns 1,605 shares of the company’s stock valued at $143,000 after buying an additional 138 shares during the period. Global X Management Co. LLC increased its position in HCA Holdings by 29.9% in the first quarter. Global X Management Co. LLC now owns 2,162 shares of the company’s stock valued at $192,000 after buying an additional 498 shares during the period. Peak Asset Management LLC bought a new position in HCA Holdings during the first quarter valued at about $201,000. Finally, Ifrah Financial Services Inc. bought a new position in HCA Holdings during the first quarter valued at about $210,000. Hedge funds and other institutional investors own 74.54% of the company’s stock.
Shares of HCA Holdings, Inc. (NYSE HCA) opened at 79.37 on Friday. The stock has a market cap of $28.67 billion, a price-to-earnings ratio of 10.64 and a beta of 0.67. The firm has a 50-day moving average price of $83.56 and a 200 day moving average price of $84.33. HCA Holdings, Inc. has a 52-week low of $67.00 and a 52-week high of $91.03.
HCA Holdings (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing the consensus estimate of $1.80 by $0.05. The firm had revenue of $10.73 billion for the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The company’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period last year, the firm earned $1.66 EPS. Analysts expect that HCA Holdings, Inc. will post $7.17 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “HCA Holdings, Inc. (NYSE:HCA) Position Raised by Boston Partners” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/08/13/hca-holdings-inc-nysehca-position-raised-by-boston-partners.html.
Several research firms have recently issued reports on HCA. Zacks Investment Research downgraded shares of HCA Holdings from a “buy” rating to a “hold” rating in a report on Friday, July 14th. BidaskClub downgraded shares of HCA Holdings from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Citigroup Inc. cut their price objective on shares of HCA Holdings from $89.00 to $87.00 and set a “neutral” rating on the stock in a report on Wednesday, July 26th. Leerink Swann upgraded shares of HCA Holdings from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $92.00 to $100.00 in a report on Tuesday, June 6th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $95.00 price objective on shares of HCA Holdings in a report on Monday, April 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $93.50.
In other news, SVP Jana Joustra Davis sold 54,689 shares of the business’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $82.35, for a total value of $4,503,639.15. Following the transaction, the senior vice president now owns 107,892 shares of the company’s stock, valued at $8,884,906.20. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $86.44, for a total value of $185,846.00. Following the completion of the transaction, the insider now directly owns 12,363 shares in the company, valued at approximately $1,068,657.72. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 138,117 shares of company stock worth $11,654,477. 2.90% of the stock is currently owned by corporate insiders.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.